Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery.
| dc.contributor.author | Jacobs, Simone | |
| dc.contributor.author | Bunt, Craig R | |
| dc.contributor.author | Wu, Zimei | |
| dc.contributor.author | Lehr, Claus-Michael | |
| dc.contributor.author | Rupenthal, Ilva D | |
| dc.date.accessioned | 2013-01-18T11:46:16Z | en |
| dc.date.available | 2013-01-18T11:46:16Z | en |
| dc.date.issued | 2012-11 | en |
| dc.identifier.citation | Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery. 2012, 38 (11):1337-43 Drug Dev Ind Pharm | en_GB |
| dc.identifier.issn | 1520-5762 | en |
| dc.identifier.pmid | 22300392 | en |
| dc.identifier.doi | 10.3109/03639045.2011.650646 | en |
| dc.identifier.uri | http://hdl.handle.net/10033/265972 | en |
| dc.description.abstract | Injectable implants are biodegradable, syringeable formulations that are injected as liquids, but form a gel inside the body due to a change in pH, ions or temperature. | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to Drug development and industrial pharmacy | en_GB |
| dc.title | Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery. | en |
| dc.type | Article | en |
| dc.contributor.department | Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany. | en_GB |
| dc.identifier.journal | Drug development and industrial pharmacy | en_GB |
| refterms.dateFOA | 2013-11-15T00:00:00Z | |
| html.description.abstract | Injectable implants are biodegradable, syringeable formulations that are injected as liquids, but form a gel inside the body due to a change in pH, ions or temperature. |
